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varied from 19 for warts, to 27 for CIN 3 and approximately
450 for cancer and was similar for the differently aged cohorts.
Results were sensitive to the duration of vaccine efﬁcacy and cov-
erage. If vaccine coverage was as low as 30%, the NNV for
warts, CIN 3 and cancer would increase to 50, 57 and 1115
respectively. If the duration of efﬁcacy was only 10 years instead
of a lifetime, the NNV would increase to 62 for warts, 67 for
CIN 3 and over 1100 for cancer. CONCLUSION: These analy-
ses suggest that the NNV for warts and cervical pre-cancer using
a quadrivalent HPV vaccine is low, but will depend on the dura-
tion of vaccine efﬁcacy as well as coverage.
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OBJECTIVES: The Functional Assessment of Cancer Therapy—
Kidney Symptom Index (FKSI) is a 15-item scale that was devel-
oped and validated to assess symptoms and concerns of
advanced kidney cancer patients. The aim of this study was to
evaluate the factor structure of FKSI for possibly useful sub-
scales and assess the reliability of the sub-scales. METHODS:
Data for this study were obtained from a phase III clinical trial
of 903 advanced renal cancer patients. Patients were adminis-
tered FKSI questionnaire at baseline. Baseline data were analyzed
using exploratory factor analysis with oblique rotation (promax)
to evaluate the dimensional structure of FKSI. The internal con-
sistency of the subscales and overall scale was assessed using
Cronbach’s alpha. RESULTS: Four factors were identiﬁed con-
sisting of 13 of the 15 items of FKSI. The ﬁrst factor had two
items related to pain symptoms; the second factor had two items
related to respiratory symptoms; the third factor had ﬁve items
related to general symptoms of the disease and; the fourth factor
had four items related to quality of life. All four factors had good
reliability (alphas > 0.70). The internal consistency of the overall
13-item scale was excellent (alpha = 0.83). CONCLUSION: A
four-factor solution consisting of 13 items could easily be labeled
with clinically-meaningful concepts, indicating the possibility of
four underlying dimensions of kidney cancer symptomatology:
pain, respiratory, general symptoms and quality of life. Findings
supported the internal consistency of four sub-scales and overall
13-item scale. Sub-scale scores and the total index are reliable
and valid measure that can be used to determine the effect of
drug therapies on speciﬁc symptoms and concerns of advanced
kidney cancer.
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OBJECTIVES: To assess Australian men’s preferences for health
states (HS) speciﬁc to advanced stage prostate cancer (APC)
including baseline diagnoses of APC, response, no response,
disease progression and especially treatment-related toxicities by
severity apart from other components of the HS which is
methodologically different. METHODS: FACT-P QOL data
from patients with APC were used to compose HS narratives
consisting of physical, social, emotional, functional well-being,
additional concerns domains. Treatment-related mild, moderate,
severe and life-threatening toxicities were described separately.
100 Australian men were recruited and interviewed using stan-
dard gamble techniques (SG). Baseline diagnoses of APC,
response, no response and disease progression using SG as usual
with oscillating risks of perfect health (1) and immediate death
(0) as anchors OR the HS narrative with 100% certainty. For
toxicities, however, the true trade-off is treatment response with
an associated risk of toxicity OR no treatment and remain with
100% certainty at baseline APC. This obtains how much chance
of response a man needs to be indifferent to the corresponding
chance of toxicity by severity. RESULTS: SG regression results
were 0.506 (p < 0.01) for baseline APC, 0.602 (p < 0.01) for
response, 0.502 (p < 0.01) for no response, and 0.318 (p < 0.01)
for disease progression. The trade-off between a chance of treat-
ment response with a corresponding chance of mild, moderate,
severe, or life-threatening toxicity yielded utility scores of 0.794
(p < 0.01), 0.715 (p < 0.01), 0.466 (p < 0.01), and 0.257 (p <
0.01), respectively. CONCLUSION: Men need at least a 21%,
28%, 55% or 74% chance of treatment response to be indiffer-
ent to treatment related toxicity depending on severity. These
measured values are more appropriate for Quality-adjusted Time
Without Symptoms of disease and Toxicity (Q-TWiST) analysis
where time without disease progression is rewarded while disease
progression with toxicities is penalized by applying a utility
weights for disease progression and time with toxicity than the
usual arbitrary ones.
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OBJECTIVES: The purpose of this study was to translate and
linguistically validate the Functional Assessment of Cancer
Therapy—Head and Neck V. 4 (FACT-H&N) for Gujarati,
Hindi, Kannada, Malayalam, Marathi, Tamil, Telugu and Urdu
translations. METHODS: The FACT-H&N was originally devel-
oped through patient and expert interviews, and validation
studies. The FACT-H&N was translated according to the stan-
dard FACIT methodology: 2 forward translations, a reconciled
version of the 2 forwards, back-translation to English, 3 inde-
pendent reviews by bilingual experts, and harmonization across
all languages. The study sample included 120 patients from 8
regions of India. Patients diagnosed with any type of head and
neck cancer completed the translated FACT-H&N and then par-
ticipated in cognitive debrieﬁng interviews. Statistical analyses
(descriptive statistics and reliability analyses) were performed on
the quantitative data, and the participant comments were ana-
lyzed qualitatively. RESULTS: Most of the languages showed
acceptable reliability ranging from 0.69 to 0.87 for the H&N
subscale despite the small sample size with the exception of
Kannada (0.13) and Tamil (0.56). There were no negative patient
comments related to the H&N speciﬁc items. However, when
item-total correlations were examined, it was found that some
items performed poorly across some languages. They included
mouth dryness, trouble breathing, and communication with
others. Of these, only the item about communication seemed to
indicate a cultural issue affecting the item’s relevance. Small
changes were made to the Telugu translation but not to the other
languages. CONCLUSION: The FACT-H&N has shown good
reliability and linguistic validity with 8 language versions. We
consider these translations to be acceptable for use in interna-
